A detailed history of Rafferty Asset Management, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 144,021 shares of EBS stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
144,021
Holding current value
$1.2 Million
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.72 - $14.77 $823,800 - $2.13 Million
144,021 New
144,021 $1.2 Million
Q2 2023

Aug 11, 2023

BUY
$7.35 - $13.21 $1.46 Million - $2.62 Million
198,538 Added 51.83%
581,625 $4.27 Million
Q1 2023

May 11, 2023

SELL
$7.79 - $16.29 $253,213 - $529,506
-32,505 Reduced 7.82%
383,087 $3.97 Million
Q4 2022

Feb 13, 2023

BUY
$11.0 - $21.45 $1.99 Million - $3.87 Million
180,609 Added 76.86%
415,592 $4.91 Million
Q3 2022

Nov 14, 2022

BUY
$20.09 - $35.8 $2.15 Million - $3.84 Million
107,256 Added 83.97%
234,983 $4.93 Million
Q2 2022

Aug 12, 2022

SELL
$27.42 - $43.63 $518,265 - $824,650
-18,901 Reduced 12.89%
127,727 $3.97 Million
Q1 2022

May 13, 2022

BUY
$36.48 - $52.22 $545,850 - $781,367
14,963 Added 11.36%
146,628 $6.02 Million
Q4 2021

Feb 10, 2022

BUY
$33.11 - $55.01 $2.55 Million - $4.24 Million
77,075 Added 141.19%
131,665 $5.72 Million
Q3 2021

Nov 10, 2021

BUY
$50.07 - $66.05 $676,946 - $892,996
13,520 Added 32.92%
54,590 $2.73 Million
Q2 2021

Aug 10, 2021

BUY
$56.61 - $80.46 $233,459 - $331,817
4,124 Added 11.16%
41,070 $2.59 Million
Q1 2021

May 10, 2021

BUY
$86.23 - $125.19 $2.23 Million - $3.23 Million
25,807 Added 231.68%
36,946 $3.43 Million
Q4 2020

Feb 10, 2021

SELL
$79.17 - $111.47 $719,813 - $1.01 Million
-9,092 Reduced 44.94%
11,139 $998,000
Q3 2020

Nov 13, 2020

BUY
$81.91 - $134.94 $307,490 - $506,564
3,754 Added 22.78%
20,231 $2.09 Million
Q2 2020

Aug 07, 2020

BUY
$54.33 - $89.52 $642,180 - $1.06 Million
11,820 Added 253.81%
16,477 $1.3 Million
Q1 2020

May 15, 2020

SELL
$49.34 - $68.76 $1.72 Million - $2.4 Million
-34,943 Reduced 88.24%
4,657 $269,000
Q4 2019

Feb 10, 2020

SELL
$51.21 - $59.06 $766,255 - $883,714
-14,963 Reduced 27.42%
39,600 $2.14 Million
Q3 2019

Nov 14, 2019

SELL
$40.6 - $57.2 $2.1 Million - $2.96 Million
-51,835 Reduced 48.72%
54,563 $2.85 Million
Q2 2019

Aug 09, 2019

BUY
$39.92 - $53.86 $1.08 Million - $1.45 Million
26,947 Added 33.92%
106,398 $5.14 Million
Q1 2019

May 15, 2019

BUY
$48.23 - $66.16 $3.83 Million - $5.26 Million
79,451 New
79,451 $4.01 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $414M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.